Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Q32 Bio Inc. - Common Stock (NQ:QTTB)

1.460 -0.030 (-2.01%)
Streaming Delayed Price Updated: 12:21 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Q32 Bio Inc. - Common Stock

12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Q32 Bio Stock Turns Retail Trader Heads After FDA Grants Fast Track For Alopecia Drug
Q32 Bio shares drew renewed attention on Wednesday after the FDA granted Fast Track designation to its experimental alopecia areata treatment, bempikibart. The designation could accelerate development... 
Via Stocktwits
Topics Stocks
This Columbus McKinnon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
QTTB Stock Earnings: Q32 Bio Misses EPS for Q2 2024
QTTB stock results show that Q32 Bio missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
QTTB Stock Earnings: Q32 Bio Misses EPS for Q1 2024
QTTB stock results show that Q32 Bio missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast
Via Benzinga
Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday?
Q32 Bio reports Phase 2a SIGNAL-AA trial results for bempikibart in alopecia areata, showing safety and modest efficacy. Trial expansion planned. 
Via Benzinga
Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations
Via Benzinga
Topics Economy
Q32 Bio Crashes 67% On A 'Messy' Update In Eczema, Alopecia Treatment
The company scrapped its treatment for eczema, though continues working in alopecia. 
Via Investor's Business Daily
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803%
Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Robotics leading at 803% and Q32 Bio at 101%. 
Via Benzinga
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.